These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 29852382)

  • 1. Widely targeted metabolomics of Alzheimer's disease postmortem cerebrospinal fluid based on 9-fluorenylmethyl chloroformate derivatized ultra-high performance liquid chromatography tandem mass spectrometry.
    Muguruma Y; Tsutsui H; Noda T; Akatsu H; Inoue K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1091():53-66. PubMed ID: 29852382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-based diagnosis of Alzheimer's disease using fingerprinting metabolomics based on hydrophilic interaction liquid chromatography with mass spectrometry and multivariate statistical analysis.
    Inoue K; Tsuchiya H; Takayama T; Akatsu H; Hashizume Y; Yamamoto T; Matsukawa N; Toyo'oka T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 974():24-34. PubMed ID: 25463194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UHPLC-QTOF/MS-based metabolomics investigation for the protective mechanism of Danshen in Alzheimer's disease cell model induced by Aβ
    Zhang M; Liu Y; Liu M; Liu B; Li N; Dong X; Hong Z; Chai Y
    Metabolomics; 2019 Jan; 15(2):13. PubMed ID: 30830431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive quantification of purine and pyrimidine metabolism in Alzheimer's disease postmortem cerebrospinal fluid by LC-MS/MS with metal-free column.
    Muguruma Y; Tsutsui H; Akatsu H; Inoue K
    Biomed Chromatogr; 2020 Feb; 34(2):e4722. PubMed ID: 31656052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new metabolomic workflow for early detection of Alzheimer's disease.
    Ibáñez C; Simó C; Barupal DK; Fiehn O; Kivipelto M; Cedazo-Mínguez A; Cifuentes A
    J Chromatogr A; 2013 Aug; 1302():65-71. PubMed ID: 23827464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Throughput Metabolomics for Discovering Potential Metabolite Biomarkers and Metabolic Mechanism from the APPswe/PS1dE9 Transgenic Model of Alzheimer's Disease.
    Yu J; Kong L; Zhang A; Han Y; Liu Z; Sun H; Liu L; Wang X
    J Proteome Res; 2017 Sep; 16(9):3219-3228. PubMed ID: 28753016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics approach to explore the effects of Kai-Xin-San on Alzheimer's disease using UPLC/ESI-Q-TOF mass spectrometry.
    Chu H; Zhang A; Han Y; Lu S; Kong L; Han J; Liu Z; Sun H; Wang X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():50-61. PubMed ID: 26896572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-specific alterations in NAD+ metabolism in 3xTg Alzheimer's disease mouse brain assessed by quantitative targeted LC-MS.
    van der Velpen V; Rosenberg N; Maillard V; Teav T; Chatton JY; Gallart-Ayala H; Ivanisevic J
    J Neurochem; 2021 Oct; 159(2):378-388. PubMed ID: 33829502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of intracellular metabolome in osteosarcoma stem cells revealed by liquid chromatography-tandem mass spectrometry.
    Zhong Z; Mao S; Lin H; Li H; Lin J; Lin JM
    Talanta; 2019 Nov; 204():6-12. PubMed ID: 31357340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 9-fluorenylmethyl chloroformate as a fluorescence-labeling reagent for derivatization of carboxylic acid moiety of sodium valproate using liquid chromatography/tandem mass spectrometry for binding characterization: a human pharmacokinetic study.
    Mohammadi B; Majnooni MB; Khatabi PM; Jalili R; Bahrami G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jan; 880(1):12-8. PubMed ID: 22173006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidylcholine and amide as metabolites for detecting alzheimer disease using ultrahigh-performance liquid chromatography-quadrupole time-of-flight mass spectrometry-based metabonomics.
    Cui Y; Liu X; Wang M; Liu L; Sun X; Ma L; Xie W; Wang C; Tang S; Wang D; Wu Q
    J Neuropathol Exp Neurol; 2014 Oct; 73(10):954-63. PubMed ID: 25192049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Alterations in the Outer Membrane Vesicles of Patients with Alzheimer's Disease: An LC-MS/MS-based Metabolomics Analysis.
    Wei SC; Wei W; Peng WJ; Liu Z; Cai ZY; Zhao B
    Curr Alzheimer Res; 2019; 16(13):1183-1195. PubMed ID: 31755388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of catecholamines and their metabolites in rat urine by ultra-performance liquid chromatography-tandem mass spectrometry for the study of identifying potential markers for Alzheimer's disease.
    Lv C; Li Q; Liu X; He B; Sui Z; Xu H; Yin Y; Liu R; Bi K
    J Mass Spectrom; 2015 Feb; 50(2):354-63. PubMed ID: 25800017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma metabolic profiling of mild cognitive impairment and Alzheimer's disease using liquid chromatography/mass spectrometry.
    Liu Y; Li N; Zhou L; Li Q; Li W
    Cent Nerv Syst Agents Med Chem; 2014; 14(2):113-20. PubMed ID: 25515716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted High Performance Liquid Chromatography Tandem Mass Spectrometry-based Metabolomics differentiates metabolic syndrome from obesity.
    Zhong F; Xu M; Bruno RS; Ballard KD; Zhu J
    Exp Biol Med (Maywood); 2017 Apr; 242(7):773-780. PubMed ID: 28299975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic and urinary metabolomics studies on the mechanism of Schisandra polysaccharide in the treatment of Alzheimer's disease.
    Liu Y; Liu Z; Wei M; Hu M; Yue K; Bi R; Zhai S; Pi Z; Song F; Liu Z
    Food Funct; 2019 Jan; 10(1):432-447. PubMed ID: 30623955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated, untargeted metabolomics analysis of cutaneous T-cell lymphoma reveals metabolic shifts in plasma and tumor adjacent skins of xenograft mice.
    Le Y; Shen X; Kang H; Wang Q; Li K; Zheng J; Yu Y
    J Mass Spectrom; 2018 Feb; 53(2):172-182. PubMed ID: 29160924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Protocol Based on UHPLC-MS/MS for Quantitation of Metabolites in Xylose-Fermenting Yeasts.
    Campos CG; Veras HCT; de Aquino Ribeiro JA; Costa PPKG; Araújo KP; Rodrigues CM; de Almeida JRM; Abdelnur PV
    J Am Soc Mass Spectrom; 2017 Dec; 28(12):2646-2657. PubMed ID: 28879550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A HILIC-UHPLC-MS/MS untargeted urinary metabonomics combined with quantitative analysis of five polar biomarkers on osteoporosis rats after oral administration of Gushudan.
    Wu X; Huang Y; Sun J; Wen Y; Qin F; Zhao L; Xiong Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():40-49. PubMed ID: 29132024
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 37.